CHM.AX Chimeric Therapeutics (ASX) up 25% pre-market 24 Jan 2026: outlook

CHM.AX stock opened pre-market on 24 Jan 2026 at A$0.0025 after a one-day move of +25.0% from the previous close. The spike places Chimeric Therapeutics Limited (ASX) among the top gainers ahead of upcoming clinical and earnings catalysts. Traders are watching volume and clinical updates for CHM 0201 and CHM 1101, which connect directly to the share move and near-term outlook.